Pharmacokinetic studies of fluconazole in rabbits characterizing doses which achieve peak levels in serum and area under the concentration-time curve values which mimic those of high-dose fluconazole in humans

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1512-1514

  Louie, Arnold ^a   Liu, Qing Feng ^a   Drusano, George L ^a   Liu, Weiguo ^a   Mayers, Martin ^b   Anaissie, Elias ^c,d   Miller, Michael H ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BRAIN TOXICITY; CANDIDA PARAPSILOSIS; DOSE RESPONSE; DRUG DESIGN; DRUG EFFICACY; DRUG HALF LIFE; FUSARIUM; INTRAVENOUS DRUG ADMINISTRATION; MATHEMATICAL ANALYSIS; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; STEADY STATE;

EID: 0031805507     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1512     Document Type: Article

References (15)

1. Akaike, H. 1974. A new look at the statistical model identification. IEEE Trans. Automated Control 19:716-723.
2. Anaissie, E. J., D. P. Kontoyiannis, C. Huls, C. Karl, R. A. Prince, J. Bosso, and G. P. Bodey. 1445. Safety, plasma concentrations, and efficacy of high-dose fluconazolc in invasive mold infections. J. Infect. Dis. 172:599-602.
3. Brammer, K. W., P. R. Farrow, and J. K. Faulkner. 1990. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12(Suppl. 3):S318-S326.
4. Filler, S. G., M. A. Crislip, C. L. Mayer, and J. E. Edwards, Jr. 1991. Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. Antimicrob. Agents Chemother. 35:288-292.
5. Grant, S. M., and S. P. Clissold. 1940. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39:877-916.
6. Jorgensen, J. H., G. A. Alexander, J. R. Graybill, and D. J. Drutz. 1981. Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob. Agents Chemother. 20:59-62.
7. Louie, A., G. L. Drusano, P. Banerjee, Q.-F. Liu, W. Liu, P. Kaw, M. Shavegani, H. Taber, and M. H. Miller. 1998. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. Antimicrob. Agents Chemother. 42:1105-1109.
8. Madu, A., C. Cioffe, U. Mian, M. Burroughs, E. Tuomanen, M. Mayers, E. Schwartz, and M. Miller. 1994. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentration in cerebrospinal fluid. Antimicrob. Agents Chemother. 38:2111-2115.
9. Patterson, T. F., D. George, P. Miniter, and V. T. Andriole. 1991. The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. J. Infect. Dis. 164:575-580.
10. Perfect, J. R., D. V. Savani, and D. T. Durack. 1986. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob. Agents Chemother. 29:579-583.
11. Slavin, M. A., B. Osborne, R. Adams, M. J. Levenstein, H. G. Schoch, A. R. Feldman, J. D. Meyers, and R. A. Bowden. 1995. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. J. Infect. Dis. 171:1545-1552.
12. Walsh, T. J., G. Foulds, and P. A. Pizzo. 1989. Pharmacokinetics and tissue penetration of fluconazole in rabbits. Antimicrob. Agents Chemother. 33: 467-469.
13. Walsh, T. J., J. Lee, S. Aoki, F. Mechinaud, J. Bacher, J. Lecciones, V. Thomas, M. Rubin, and P. A. Pizzo. 1990. Experimental basis for use of fluconazole for prevention or early treatment of disseminated candidiasis in granulocytopenic hosts. Rev. Infect. Dis. 12(Suppl. 3):S307-S317.
14. Witt, M. D., and A. S. Bayer. 1991. Comparison of fluconazole and amphotericin B for the prevention and treatment of experimental Candida endocarditis. Antimicrob. Agents Chemother. 35:2481-2485.
15. Witt, M. D., T. Imhoff, C. Li, and A. S. Bayer. 1993. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. Antimicrob. Agents Chemother. 37: 2030-2032.